Bonitas is Short AFC Gamma (Nasdaq: $AFCG). We think that AFCG materially overstated AFCG’s investment income and understated portfolio losses in order to pay out exorbitant fees to Tannenbaum’s AFCM at the expense of AFCG shareholders. Full report at bonitasresearch.com

Bonitas is Short Cibus (Nasdaq: $CBUS). We found no evidence that Cibus’ gene-editing technology brings desirable new crops to market. Instead, we found farmer complaints of lower crop yields and lost revenues, along with multiple examples of large seed manufacturers and

Bonitas is Short Byrna (Nasdaq: $BYRN) Overstated Premier Dealership Count; Stagnant Amazon Sales and Google Trends; Increased Competition; Insider Sales; CFO Turnover We are short BYRN and think its stock is going lower. Full report at bonitasresearch.com